HomeCompareBABX vs JNJ

BABX vs JNJ: Dividend Comparison 2026

BABX yields 8.10% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BABX wins by $14.2K in total portfolio value
10 years
BABX
BABX
● Live price
8.10%
Share price
$24.68
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$1,353.09
Full BABX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BABX vs JNJ

📍 BABX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBABXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BABX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BABX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BABX
Annual income on $10K today (after 15% tax)
$688.82/yr
After 10yr DRIP, annual income (after tax)
$1,150.13/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, BABX beats the other by $446.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BABX + JNJ for your $10,000?

BABX: 50%JNJ: 50%
100% JNJ50/50100% BABX
Portfolio after 10yr
$27.1K
Annual income
$1,090.44/yr
Blended yield
4.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BABX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BABX buys
0
JNJ buys
0
No recent congressional trades found for BABX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBABXJNJ
Forward yield8.10%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$34.2K$20.0K
Annual income after 10y$1,353.09$827.78
Total dividends collected$10.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BABX vs JNJ ($10,000, DRIP)

YearBABX PortfolioBABX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,510$810.37$10,676$355.77+$834.00BABX
2$13,188$871.75$11,407$389.39+$1.8KBABX
3$15,044$933.45$12,198$426.53+$2.8KBABX
4$17,093$995.20$13,056$467.62+$4.0KBABX
5$19,346$1,056.72$13,987$513.12+$5.4KBABX
6$21,818$1,117.78$14,998$563.56+$6.8KBABX
7$24,523$1,178.14$16,098$619.52+$8.4KBABX
8$27,478$1,237.59$17,295$681.69+$10.2KBABX
9$30,697$1,295.97$18,599$750.82+$12.1KBABX
10$34,199$1,353.09$20,022$827.78+$14.2KBABX

BABX vs JNJ: Complete Analysis 2026

BABXStock

The Fund seeks daily investment results, before fees and expenses, of 2 times (200%) the daily percentage change of the common stock of Alibaba Group Holding Limited, (NASDAQ: BABA) There is no guarantee that the Fund will meet its stated objective. The fund should not be expected to provide 2 times the cumulative return of BABA for periods greater than a day.

Full BABX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BABX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BABX vs SCHDBABX vs JEPIBABX vs OBABX vs KOBABX vs MAINBABX vs ABBVBABX vs MRKBABX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.